Nisa Investment Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Nisa Investment Advisors, LLC

  • $16.7 Billion
  • Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 75,350 shares of VRTX stock, worth $30.8 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
75,350
Previous 73,129 3.04%
Holding current value
$30.8 Million
Previous $34.3 Million 2.23%
% of portfolio
0.21%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$460.0 - $505.78 $1.02 Million - $1.12 Million
2,221 Added 3.04%
75,350 $35 Million
Q2 2024

Jul 19, 2024
BUY
$392.81 - $485.53 $1.05 Million - $1.29 Million
2,662 Added 3.78%
73,129 $34.3 Million
Q1 2024

May 01, 2024
SELL
$407.69 - $446.08 $2.51 Million - $2.75 Million
-6,158 Reduced 8.04%
70,467 $29.5 Million
Q4 2023

Jan 25, 2024
SELL
$343.0 - $410.68 $76,146 - $91,170
-222 Reduced 0.29%
76,625 $31.2 Million
Q3 2023

Nov 02, 2023
SELL
$338.18 - $362.46 $972,267 - $1.04 Million
-2,875 Reduced 3.61%
76,847 $26.7 Million
Q2 2023

Aug 11, 2023
SELL
$314.42 - $351.91 $544,889 - $609,860
-1,733 Reduced 2.13%
79,722 $28.1 Million
Q1 2023

May 02, 2023
BUY
$283.23 - $323.1 $545,217 - $621,967
1,925 Added 2.42%
81,455 $25.7 Million
Q4 2022

Feb 02, 2023
SELL
$285.76 - $321.48 $442,928 - $498,294
-1,550 Reduced 1.91%
79,530 $23 Million
Q3 2022

Nov 07, 2022
BUY
$273.83 - $305.53 $1.37 Million - $1.53 Million
4,999 Added 6.57%
81,080 $23.5 Million
Q2 2022

Aug 03, 2022
BUY
$234.96 - $292.55 $238,249 - $296,645
1,014 Added 1.35%
76,081 $21.4 Million
Q1 2022

Apr 29, 2022
SELL
$221.42 - $260.97 $2.43 Million - $2.87 Million
-10,995 Reduced 12.78%
75,067 $19.6 Million
Q4 2021

Feb 03, 2022
SELL
$177.01 - $223.45 $1 Million - $1.26 Million
-5,652 Reduced 6.16%
86,062 $20.9 Million
Q3 2021

Oct 18, 2021
SELL
$181.39 - $202.99 $2.01 Million - $2.25 Million
-11,072 Reduced 10.77%
91,714 $16.6 Million
Q2 2021

Aug 06, 2021
BUY
$187.49 - $221.1 $433,476 - $511,183
2,312 Added 2.3%
102,786 $20.7 Million
Q1 2021

Apr 26, 2021
BUY
$207.02 - $241.31 $91,088 - $106,176
440 Added 0.44%
100,474 $21.6 Million
Q4 2020

Jan 25, 2021
SELL
$207.01 - $276.09 $987,023 - $1.32 Million
-4,768 Reduced 4.55%
100,034 $23.6 Million
Q3 2020

Oct 20, 2020
SELL
$255.65 - $303.1 $6.54 Million - $7.75 Million
-25,566 Reduced 19.61%
104,802 $28.5 Million
Q2 2020

Jul 27, 2020
BUY
$225.48 - $295.8 $4.2 Million - $5.52 Million
18,646 Added 16.69%
130,368 $37.8 Million
Q1 2020

Apr 17, 2020
BUY
$199.77 - $247.81 $1.64 Million - $2.04 Million
8,217 Added 7.94%
111,722 $26.6 Million
Q4 2019

Jan 17, 2020
BUY
$166.71 - $223.91 $1.38 Million - $1.86 Million
8,288 Added 8.7%
103,505 $22.7 Million
Q3 2019

Oct 17, 2019
SELL
$166.23 - $187.09 $1.01 Million - $1.13 Million
-6,053 Reduced 5.98%
95,217 $16.1 Million
Q2 2019

Jul 12, 2019
SELL
$164.61 - $190.37 $800,498 - $925,769
-4,863 Reduced 4.58%
101,270 $18.6 Million
Q1 2019

Apr 17, 2019
BUY
$163.73 - $194.7 $553,407 - $658,086
3,380 Added 3.29%
106,133 $19.5 Million
Q4 2018

Jan 17, 2019
SELL
$151.91 - $192.21 $395,117 - $499,938
-2,601 Reduced 2.47%
102,753 $17 Million
Q3 2018

Oct 16, 2018
BUY
$167.73 - $192.74 $2.2 Million - $2.53 Million
13,117 Added 14.22%
105,354 $20.3 Million
Q2 2018

Jul 19, 2018
BUY
$145.72 - $169.96 $241,020 - $281,113
1,654 Added 1.83%
92,237 $15.7 Million
Q1 2018

Apr 10, 2018
BUY
$151.6 - $177.13 $106,271 - $124,168
701 Added 0.78%
90,583 $14.8 Million
Q4 2017

Jan 12, 2018
BUY
$137.28 - $155.55 $1.58 Million - $1.79 Million
11,489 Added 14.66%
89,882 $13.5 Million
Q3 2017

Oct 13, 2017
BUY
$148.13 - $162.24 $11.6 Million - $12.7 Million
78,393
78,393 $11.9 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email